The Current Ratio as of December 2025 (TTM) for Kairos Pharma, Ltd. (KAPA) is 16.56

According to Kairos Pharma, Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 16.56. This represents a change of 86.91% compared to the average of 8.86 of the last 4 quarters.

Kairos Pharma, Ltd. (KAPA) Historical Current Ratio (quarterly & annually)

How has KAPA Current Ratio performed in the past?

The mean historical Current Ratio of Kairos Pharma, Ltd. over the last ten years is 0.92. The current 16.56 Current Ratio has changed 180.27% with respect to the historical average. Over the past ten years (40 quarters), KAPA's Current Ratio was at its highest in in the September 2025 quarter at 16.56. The Current Ratio was at its lowest in in the March 2022 quarter at 0.

Kairos Pharma, Ltd. (KAPA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kairos Pharma, Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kairos Pharma, Ltd. (KAPA) Average Current Ratio

How has KAPA Current Ratio performed in the past?

The current Current Ratio of Kairos Pharma, Ltd. (KAPA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kairos Pharma, Ltd. (KAPA) Current Ratio vs. Peers

How is KAPA’s Current Ratio compared to its peers?

Kairos Pharma, Ltd.’s Current Ratio is greater than Lixte Biotechnology Holdings, Inc. (1.84), greater than Pelthos Therapeutics Inc. (1.98), greater than Lexaria Bioscience Corp. (3.90), greater than CASI Pharmaceuticals, Inc. (0.30), greater than Allarity Therapeutics, Inc. (2.33), greater than Clearside Biomedical, Inc. (3.87), greater than Cingulate Inc. (1.26), greater than BriaCell Therapeutics Corp. (3.41), greater than Entero Therapeutics, Inc. (2.62), less than Pulmatrix, Inc. (19.97),

Build a custom stock screener for Kairos Pharma, Ltd. (KAPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kairos Pharma, Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kairos Pharma, Ltd. (KAPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kairos Pharma, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.